NorthRock Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
NorthRock Partners's RMD Position: Q4 2025 in Review
NorthRock Partners sold out of ResMed (RMD) in Q4 2025, closing a stake of 2,826 shares — an estimated $774K sold.
NorthRock Partners first reported a position in RMD in Q3 2019 and held it in 20 quarters. The position peaked at $774K in Q3 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.
- NorthRock Partners reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
- NorthRock Partners sold 2,826 ResMed shares in Q4 2025, an estimated $774K.
- NorthRock Partners first reported a position in ResMed in Q3 2019 and held it in 20 quarters.
- NorthRock Partners's ResMed position peaked at $774K in Q3 2025.
- 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.
Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.